Glow LifeTech (TSE:GLOW)
:GLOW
Want to see TSE:GLOW full AI Analyst Report?
GLOW Stock Chart & Stats
C$0.06
>-C$0.01(-7.69%)
At close: 4:00 PM EST
C$0.06
>-C$0.01(-7.69%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.08
Previous CloseN/A
Volume6.00K
Average Volume (3M)266.05K
Market Cap
C$8.65M
Enterprise ValueC$7.11M
Total Cash (Recent Filing)C$1.59M
Total Debt (Recent Filing)C$45.48K
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding192,235,550
10 Day Avg. Volume165,602
30 Day Avg. Volume266,047
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained ~86% revenue growth shows expanding commercial traction and product adoption, increasing the size of the addressable cash-generating base. Over months this scale supports future margin improvement, lowers per-unit costs and reduces reliance on financing if growth persists.
Low Financial LeverageVery low debt gives the company financial flexibility to fund R&D or clinical programs without heavy interest burdens. That durability reduces near-term solvency risk and preserves optionality to pursue partnerships or bridge financing when cash generation remains weak.
Improving Free Cash Flow TrendMaterial improvement in free cash flow signals operational progress toward cash generation. Even if still negative, a clear improvement trajectory reduces required external funding and indicates management is moving closer to sustainable operations over the coming quarters.
Bears Say
Negative Operating Cash FlowPersistent negative operating cash flow means the business is burning cash and remains dependent on financing or reserves. Over a multi-month horizon this elevates dilution and refinancing risk and constrains the company’s ability to scale without external capital.
Persistent Operating LossesNegative operating profit and EBITDA show the company has not yet achieved a self-sustaining earnings model. Continued losses imply ongoing investment/burn and increase execution risk that margins won’t recover quickly enough to eliminate funding needs within the next several quarters.
Balance-sheet Volatility / Prior Negative EquityA record of balance-sheet volatility and past negative equity signals a higher tail risk if losses persist. This structural fragility can force dilutive financings, asset sales, or restrictive covenants, reducing strategic flexibility over the medium term.
Glow LifeTech News
GLOW FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was C$0.04 and its highest was C$0.07 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is C$8.65M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Sep 01, 2026 which is in 80 days.
How were Glow LifeTech’s earnings last quarter?
Currently, no data Available
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,235,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in TSE:GLOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―
Options Prices
Currently, No data available
---